← Back to all clusters

Cluster 160

9 diseases · 19 shared-gene connections
9 Diseases
21 Unique genes
0.245 Avg. similarity score
Anonychia Most-connected disease (6 links)
Log in to save this analysis

Save This Analysis

Disease Searched: Dystrophic epidermolysis bullosa Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details · click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) · drag a node to pin it in place · scroll/pinch to zoom.

Member diseases (most connected first ‐ the cluster's core)

Top shared genes (genes linked to 2+ member diseases)

Gene ⇵ Member diseases ⇵ Linked diseases
COL7A1 7 / 9 Anonychia, Dominant dystrophic epidermolysis bullosa with absence of skin, Dominant dystrophic epidermolysis bullosa, albopapular type, Duane retraction syndrome and 3 more
KRT17 3 / 9 Anonychia, Pachyonychia congenita, Sebocystomatosis
What do these columns mean?
Connections in cluster
How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
Significant partners
How many of those links are statistically significant (FDR q < 0.05).
Curated genes
Distinct curated genes linked to that disease in GeDiPNet.
Member diseases (Top shared genes)
How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
Overlap genes (x / y)
x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
Cluster gene count
Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
Fold enrichment
Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
P-value / FDR q-value
Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
Shared genes (Pairs within this cluster)
Number of curated genes the two diseases in that row have in common.
Similarity score (Pairs within this cluster)
Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.

Enriched Pathways (why this cluster is grouped, biologically)

Pathway ⇵ Source ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
Formation of the cornified envelope Reactome 4 / 130 17.6× 6.80e-5 1.71e-3 ✓ sig.
Keratinization Reactome 4 / 152 15.1× 1.25e-4 2.77e-3 ✓ sig.
Parkinson disease KEGG 4 / 268 8.5× 1.08e-3 1.49e-2 ✓ sig.
Estrogen signaling pathway KEGG 3 / 139 12.3× 1.73e-3 2.13e-2 ✓ sig.
Signaling by SCF-KIT Reactome 2 / 37 30.9× 1.87e-3 2.26e-2 ✓ sig.
Collagen degradation Reactome 2 / 52 22.0× 3.66e-3 3.64e-2 ✓ sig.
Motor proteins KEGG 3 / 194 8.8× 4.45e-3 4.19e-2 ✓ sig.
MET activates PTPN11 Reactome 1 / 5 114× 8.71e-3 6.50e-2
Pathways of neurodegeneration - multiple diseases KEGG 4 / 480 4.8× 8.78e-3 6.54e-2
Salmonella infection KEGG 3 / 248 6.9× 8.79e-3 6.54e-2
Gap junction KEGG 2 / 89 12.9× 1.04e-2 7.28e-2
Staphylococcus aureus infection KEGG 2 / 99 11.6× 1.28e-2 8.22e-2
MAPK1 (ERK2) activation Reactome 1 / 9 63.5× 1.56e-2 9.30e-2
Huntington disease KEGG 3 / 308 5.6× 1.58e-2 9.35e-2
Parathyroid hormone synthesis, secretion and action KEGG 2 / 115 9.9× 1.70e-2 9.75e-2

Enriched GO Terms (Biological Process, a second line of biological evidence)

GO term ⇵ GO ID ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
morphogenesis of an epithelium GO:0002009 4 / 51 69.8× 2.85e-7 3.00e-5 ✓ sig.
intermediate filament organization GO:0045109 4 / 70 50.8× 1.03e-6 8.64e-5 ✓ sig.
keratinization GO:0031424 4 / 73 48.8× 1.22e-6 9.97e-5 ✓ sig.
Sertoli cell development GO:0060009 2 / 13 137× 9.31e-5 2.98e-3 ✓ sig.
negative regulation of chondrocyte differentiation GO:0032331 2 / 23 77.4× 3.00e-4 6.97e-3 ✓ sig.
motor neuron axon guidance GO:0008045 2 / 24 74.2× 3.27e-4 7.36e-3 ✓ sig.
platelet-derived growth factor receptor signaling pathway GO:0048008 2 / 33 53.9× 6.22e-4 1.15e-2 ✓ sig.
homeostasis of number of cells within a tissue GO:0048873 2 / 38 46.8× 8.25e-4 1.38e-2 ✓ sig.
epithelial cell proliferation involved in prostatic bud elongation GO:0060517 1 / 1 890× 1.12e-3 1.68e-2 ✓ sig.
regulation of cell proliferation involved in tissue homeostasis GO:0060784 1 / 1 890× 1.12e-3 1.68e-2 ✓ sig.
regulation of branching involved in lung morphogenesis GO:0061046 1 / 1 890× 1.12e-3 1.68e-2 ✓ sig.
cell proliferation involved in heart morphogenesis GO:0061323 1 / 1 890× 1.12e-3 1.68e-2 ✓ sig.
regulation of epithelial cell proliferation involved in lung morphogenesis GO:2000794 1 / 1 890× 1.12e-3 1.68e-2 ✓ sig.
adherens junction disassembly GO:0120179 1 / 1 890× 1.12e-3 1.68e-2 ✓ sig.
rhombomere 6 development GO:0021572 1 / 1 890× 1.12e-3 1.68e-2 ✓ sig.

Pairs within this cluster, by significance

Disease A ⇵ Disease B ⇵ Similarity score ⇵ Shared genes ⇵ P-value ⇵ FDR q-value ⇵
Dominant dystrophic epidermolysis bullosa with absence of skin Dominant dystrophic epidermolysis bullosa, albopapular type 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Dominant dystrophic epidermolysis bullosa with absence of skin Dystrophic epidermolysis bullosa 0.333 1 1.30e-4 3.93e-4 ✓ sig.
Dominant dystrophic epidermolysis bullosa with absence of skin Nail dystrophy 0.333 1 1.30e-4 3.93e-4 ✓ sig.
Dominant dystrophic epidermolysis bullosa with absence of skin Hallopeau siemens disease 0.333 1 1.30e-4 3.93e-4 ✓ sig.
Dominant dystrophic epidermolysis bullosa, albopapular type Dystrophic epidermolysis bullosa 0.333 1 1.30e-4 3.93e-4 ✓ sig.
Dominant dystrophic epidermolysis bullosa, albopapular type Nail dystrophy 0.333 1 1.30e-4 3.93e-4 ✓ sig.
Dominant dystrophic epidermolysis bullosa, albopapular type Hallopeau siemens disease 0.333 1 1.30e-4 3.93e-4 ✓ sig.
Hallopeau siemens disease Nail dystrophy 0.250 1 2.60e-4 6.51e-4 ✓ sig.
Dystrophic epidermolysis bullosa Nail dystrophy 0.250 1 2.60e-4 6.51e-4 ✓ sig.
Dystrophic epidermolysis bullosa Hallopeau siemens disease 0.250 1 2.60e-4 6.51e-4 ✓ sig.
Anonychia Sebocystomatosis 0.200 1 2.60e-4 6.51e-4 ✓ sig.
Anonychia Dominant dystrophic epidermolysis bullosa with absence of skin 0.200 1 2.60e-4 6.51e-4 ✓ sig.
Pachyonychia congenita Sebocystomatosis 0.200 1 2.60e-4 6.51e-4 ✓ sig.
Anonychia Dominant dystrophic epidermolysis bullosa, albopapular type 0.200 1 2.60e-4 6.51e-4 ✓ sig.
Anonychia Dystrophic epidermolysis bullosa 0.167 1 5.19e-4 1.06e-3 ✓ sig.
Anonychia Hallopeau siemens disease 0.167 1 5.19e-4 1.06e-3 ✓ sig.
Dominant dystrophic epidermolysis bullosa, albopapular type Duane retraction syndrome 0.077 1 7.79e-4 1.41e-3 ✓ sig.
Dominant dystrophic epidermolysis bullosa with absence of skin Duane retraction syndrome 0.077 1 7.79e-4 1.41e-3 ✓ sig.
Anonychia Pachyonychia congenita 0.125 1 1.04e-3 1.74e-3 ✓ sig.